Nanotechnology for cancer research: Toward next generation nanomedicine addressing cancer complexity

, Lire cette page en français , Share

The Institut National du Cancer (INCa), the National Cancer Institute (NCI) of the National Institutes of Health, U.S. Department of Health & Human Services, the ITMO Cancer, the ITMO Health Technologies of the French National Alliance for Life Sciences and Health (Aviesan) and the NCI Alliance for Nanotechnology in Cancer invite you to:

Nanotechnology for cancer research Toward next generation nanomedicine addressing cancer complexity

  • When: 9-10 November 2016
  • Where: Palais Brongniart, Paris, France
  • More information & RSVP on the event website:

This symposium will provide the opportunity to carry out a multidisciplinary discussion to assess novel and already adopted translational methodologies aimed to better characterize, target and modulate tumor complexity, while addressing societal and ethical aspects of implementing these technologies.

This Franco-American symposium will report the challenges of nanotechnologies implementation in oncology toward next generation medicine with a particular focus on the new tools to address tumor complexity, cancer activity mapping and tumor microenvironment reengineering thanks to the keynote lectures of Prof. Michael Roukes and Prof. Rakesh Jain and the presentations of world renowned French and American scientists.

Keynotes Speakers:

- Michael Roukes, Caltech, Los Angeles, USA
- Rakesh Jain, Massachusetts General Hospital, Boston, USA